BVA decisions by condition

Arteriosclerotic heart disease (coronary artery disease): BVA grant rates and what wins

From 2017 to 2026, the Board of Veterans' Appeals decided a arteriosclerotic heart disease (coronary artery disease) issue in 11,747 decisions. It granted the arteriosclerotic heart disease (coronary artery disease) issue in 27.8% of them, above the 19.4% grant rate for all conditions, denied it in 35.4%, and remanded it in 35.3%. Counting only decisions on the merits (granted or denied), 44.0% were granted.

Decisions

11,747

2017–2026

Granted

27.8%

All conditions: 19.4%

Granted on the merits

44.0%

Granted ÷ (granted + denied)

Remanded

35.3%

Denied: 35.4%

Arteriosclerotic heart disease (coronary artery disease) outcomes by year

YearDecisionsGrantedDeniedRemanded
2017
612
13.9%45.9%33.5%
2018
1,039
16.8%44.0%35.8%
2019
1,419
23.6%37.0%37.9%
2020
1,629
23.6%34.8%40.8%
2021
1,444
28.1%35.5%35.3%
2022
1,510
33.7%33.6%31.9%
2023
1,461
33.3%32.0%33.9%
2024
1,104
33.3%30.1%35.6%
2025
1,042
31.6%33.1%34.7%
2026
487
39.0%34.1%26.7%

Evidence in granted and denied arteriosclerotic heart disease (coronary artery disease) decisions

For each kind of supporting evidence: how often the Board granted the arteriosclerotic heart disease (coronary artery disease) issue on the merits when the decision mentioned it, compared with decisions that did not. These are associations, not causes, and evidence is recorded per decision, not per issue.

In the recordDecisionsGranted when presentWhen absentDifference
Positive nexus opinion1,48865.4%40.1%+25.3 pts
Buddy statement52267.2%42.7%+24.5 pts
Favorable VA exam1,31561.9%40.9%+21.0 pts
Combat service91854.1%43.1%+11.0 pts
Claimed as secondary2,42351.0%42.8%+8.3 pts
Treating physician opinion78547.4%43.7%+3.7 pts
Private medical opinion4,14743.8%44.1%−0.3 pts
Lay statement8,60041.5%53.0%−11.6 pts
  • The Board applied the benefit-of-the-doubt rule (38 CFR 3.102) in 70.3% of the decisions that granted arteriosclerotic heart disease (coronary artery disease).
  • The Board found the veteran's statements credible in 37.6% of grants and 10.8% of denials.

Negative evidence in the record

An unfavorable exam or a negative nexus opinion often sits in the same record as favorable evidence, and the Board weighs them against each other. So these rows show how often arteriosclerotic heart disease (coronary artery disease) was still granted when the record contained the negative item, not that the item helped.

In the recordDecisionsGranted when presentWhen absentDifference
Negative nexus opinion4,36433.1%51.0%−17.9 pts
Unfavorable VA exam7,17734.8%63.1%−28.4 pts

Why the Board granted or denied arteriosclerotic heart disease (coronary artery disease)

Most common reasons in grants

  1. Current diagnosis established504
  2. Veteran served in thailand during vietnam era79
  3. Presumed exposure to herbicide agents52
  4. Caused by the service-connected disability45
  5. Conceded herbicide exposure35
  6. Presumption of herbicide exposure due to vietnam service30
  7. Ischemic heart disease is presumptively linked to herbicide exposure30
  8. Veteran diagnosed with cad30

Most common reasons in denials

  1. Preponderance of the evidence against the claim486
  2. No in-service complaints, treatment or diagnosis346
  3. Service records negative or silent261
  4. No current diagnosis251
  5. VA examiner: less likely than not related to service223
  6. No continuity of symptomatology131
  7. Current diagnosis established114
  8. No evidence of herbicide exposure67

Numbers are decisions that gave the reason. Reasons are short phrases extracted by AI from each decision; common wordings of the same reason are grouped. Benefit of the doubt is reported above.

Recent arteriosclerotic heart disease (coronary artery disease) decisions

Granted

Citation Nr. A26040643Jennifer Hwa · 2026

Private medical opinion from treating provider found more probative; Opinion linked heart disability to military service in Iraq; Addressed Veteran's specific history and lack of risk factors; Resolved doubt in Veteran's favor

Citation Nr. A26040465T. Raymond · 2026

Current ischemic heart disease diagnosis.; Qualifying service in the Republic of Vietnam.; Presumptive link to herbicide exposure under 38 U.S.C. § 1116A.

Citation Nr. A26040684Michael J. Skaltsounis · 2026

CAD is eligible for presumptive service connection based on herbicide exposure.; No presumptive service connection due to lack of Vietnam service or documented AO exposure.; Board found evidence in approximate balance for direct service connection of herbicide exposure.; Veteran's lay statements regarding AO exposure were found credible and probative.; Benefit of the doubt applied to grant direct service connection.

Denied

Citation Nr. 26005112Michelle L. Kane · 2026

No evidence of herbicide exposure in Taiwan.; No evidence of radiation exposure.; Condition did not onset during service or within one year of separation.; No continuity of symptoms from service to diagnosis.

Citation Nr. A26040464Jennifer White · 2026

No established in-service event (herbicide exposure); Service treatment records negative for heart disability; No VA examination required due to lack of in-service event

Citation Nr. A26040509M. C. Graham · 2026

Heart failure symptoms at >5-7 METs; Evidence weighs against higher rating; Benefit-of-the-doubt rule not applicable

Rules that apply to arteriosclerotic heart disease (coronary artery disease) claims

Research your arteriosclerotic heart disease (coronary artery disease) case

Narrow by year, judge, evidence or secondary condition, read the decisions, and export a research memo.

Open VA Law Explorer

How these numbers are calculated

  • Rates count decisions in which the Board decided a arteriosclerotic heart disease (coronary artery disease) issue, by the outcome of that issue. Other issues in the same decision can have different outcomes.
  • “Granted on the merits” leaves out remands and dismissals. “All conditions” is the grant share across every condition issue in the data.
  • The data comes from CaseScribe's AI extraction of public BVA decisions (2017–2026) and can contain errors. It is updated automatically as new decisions are added.